Sign Up Now for Our Newsletter: "The Pii Formula" and gain valuable insights   Subscribe
Mr. Brian Sasaki Joins Pharmaceutics International, Inc. (Pii) as Director of Business Development – November 13th, 2020

PRESS RELEASE Hunt Valley, MD (November 13, 2020) Mr. Brian Sasaki has joined Pharmaceutics International, Inc. (Pii) as the Director of Business Development.

Brian SasakiBrian Sasaki has over 20 years of experience in the pharmaceutical industry and is responsible for Pii’s business development operations in the Western Region of the United States.

Brian brings a vast range of scientific experience helping clients advance pharmaceutical products. Brian’s addition to the Pii team is part of a strategic effort to deliver better results faster for customers by reimagining the drug development process using phase-appropriate methods and outcomes-oriented collaboration.

Brian began his career as a bench scientist with Bayer Corporation. His range of experiences includes roles with Pfizer, Takeda/Abbott, GE, Lonza, Catalent, and Rapid Micro Biosystems. He has been at the center of solving some of the industry’s most vexing problems with innovative thinking throughout his career.  Working with client drug sponsors and using his extensive skills to help them accomplish their objectives is his passion.

Brian earned his Bachelor of Science in Microbiology, with a Minor in Chemistry, at San Jose State University.

Pharmaceutics International, Inc. (Pii) is a US-based contract development and manufacturing organization (CDMO) with a passion for solving problems. Pii’s Hunt Valley, Maryland campus includes 70 manufacturing suites with four integrated aseptic filling lines delivering quality, safety, and efficiency. Our professionals have extensive experience with small and large molecule compounds, developing and manufacturing complex parenteral drugs, extended-release formulations, non-aqueous injectable drug products, and lyophilization. Learn more at https://www.pharm-int.com/.

DOWNLOAD ARTICLE

Like what you read? Share with your network: